background
middl
east
respiratori
syndrom
coronaviru
merscov
first
identifi
human
systemat
literatur
review
conduct
synthes
current
knowledg
identifi
critic
knowledg
gap
materi
method
conduct
systemat
review
merscov
use
prisma
guidelin
identifi
relev
peerreview
public
select
base
contribut
four
key
area
virolog
clinic
characterist
outcom
therapeut
prevent
option
epidemiolog
transmiss
anim
interfac
search
natur
host
merscov
result
dipeptidyl
peptidas
identifi
human
receptor
merscov
varieti
molecular
serolog
assay
develop
dromedari
camel
remain
document
zoonot
sourc
human
infect
merslik
cov
detect
bat
speci
global
well
dromedari
camel
throughout
middl
east
africa
howev
despit
evid
cameltohuman
merscov
transmiss
case
appar
relat
camel
contact
sourc
mani
primari
case
remain
unknown
sustain
health
careassoci
human
outbreak
saudi
arabia
south
korea
latter
origin
one
travel
return
middl
east
transmiss
mechan
poorli
understood
health
care
may
includ
environment
contamin
variou
potenti
therapeut
identifi
yet
evalu
human
clinic
trial
least
one
candid
vaccin
progress
phase
trial
conclus
substanti
merscov
research
sinc
signific
knowledg
gap
persist
especi
epidemiolog
natur
histori
infect
rigor
studi
baselin
preval
transmiss
spectrum
diseas
term
camel
exposur
epidemiolog
relationship
case
clearli
defin
standard
strongli
recommend
share
access
registri
databas
coronavirus
like
continu
emerg
argu
unifi
one
health
approach
eptemb
saw
identif
novel
human
coronaviru
known
middl
east
respiratori
syndrom
coronaviru
merscov
promedmail
zaki
et
al
merscov
betacoronaviru
distinct
genet
relat
sar
sever
acut
respiratori
syndrom
coronaviru
hilgenfeld
peiri
de
wit
et
al
mer
identifi
year
sar
outbreak
spread
across
contin
rais
pandem
concern
continu
concern
pandem
potenti
merscov
hilgenfeld
peiri
de
wit
et
al
assess
anticip
potenti
epidem
spread
merscov
essenti
better
understand
virolog
human
clinic
characterist
possibl
therapeut
prevent
option
epidemiolog
transmiss
anim
interfac
possibl
origin
natur
host
mer
first
identifi
patient
lower
respiratori
diseas
physician
saudi
arabia
subsequ
viru
identifi
character
patient
sputum
sampl
research
saudi
arabia
erasmu
medic
center
netherland
sinc
decemb
laboratoryconfirm
merscov
case
death
across
countri
crude
case
fig
show
gulf
countri
least
one
laboratoryconfirm
human
merscov
case
darker
shade
indic
greater
number
laboratoryconfirm
case
data
sourc
world
health
organ
wwwwhointemergenciesmerscoven
map
gener
use
r
softwar
r
foundat
statist
comput
vienna
austria
googlevi
packag
gesmann
et
al
merscov
middl
east
respiratori
syndrom
coronaviru
fatal
rate
cfr
report
fig
major
case
death
report
saudi
arabia
world
health
organ
world
health
organizationemro
case
continu
occur
world
health
organizationemro
although
first
known
merscov
case
jordan
confirm
retrospect
sourc
still
unknown
hijawi
et
al
merscov
case
origin
pass
saudi
arabia
infect
like
zoonot
although
origin
transmiss
poorli
understood
dromedari
camel
one
document
sourc
human
zoonot
infect
memish
et
al
systemat
review
merscov
research
conduct
survey
current
understand
merscov
identifi
research
gap
four
major
area
virolog
clinic
characterist
outcom
therapeut
prevent
option
epidemiolog
transmiss
anim
interfac
search
natur
host
merscov
conduct
systemat
literatur
review
use
embas
googl
scholar
medlinepubm
supplement
thomsonreut
web
scienc
databas
identifi
peerreview
publish
articl
merscov
avail
juli
search
articl
publish
onward
sinc
mer
first
identifi
follow
search
term
use
databas
match
titl
googl
scholar
titl
abstract
embas
medlinepubm
topic
web
scienc
novel
coronaviru
novel
coronaviru
emc
novel
coronaviru
erasmu
hcovemc
merscov
pubm
mesh
term
mer
coronaviru
middl
east
respiratori
syndrom
middl
east
respiratori
syndrom
coronaviru
pubm
mesh
term
review
titl
abstract
result
citat
identifi
relev
articl
systemat
review
follow
prisma
guidelin
fig
moher
et
al
nondupl
articl
exclud
opinion
editori
piec
merscov
relat
topic
retriev
fulltext
version
index
citat
inclus
criteria
peerreview
primari
research
articl
merscov
publish
midjuli
inclus
period
updat
ad
uniqu
inform
merscov
knowledg
base
within
least
one
four
key
theme
virolog
clinic
characterist
outcom
therapeut
prevent
option
epidemiolog
transmiss
anim
interfac
search
natur
host
merscov
english
languag
public
englishlanguag
abstract
avail
includ
titl
retriev
uniqu
nondupl
scientif
research
work
relev
merscov
origin
includ
review
base
inclus
criteria
interim
updat
made
articl
prepar
pathogen
caus
mer
identifi
coronaviru
name
merscov
classifi
famili
coronavirida
subfamili
coronavirina
ictv
coronavirus
famili
envelop
approxim
spheric
positivesens
singlestrand
rna
virus
genom
length
kilobas
kb
four
describ
coronaviru
genera
alphaand
betacoronavirus
believ
origin
bat
speci
wherea
gammaand
deltacoronavirus
believ
avian
origin
woo
et
al
within
betacoronaviru
genu
four
lineag
describ
b
includ
sarscov
c
merscov
betacoronaviru
lineag
c
first
lineag
known
infect
human
two
main
recogn
clade
genet
sublineag
merscov
clade
includ
earliest
known
merscov
strain
clade
b
includ
newer
case
although
addit
genotyp
reveal
genom
sequenc
suggest
exist
addit
clade
genom
merscov
kb
encod
protein
replicas
polyprotein
orf
includ
rnadepend
rna
polymeras
rdrp
structur
protein
envelop
e
membran
n
nucleocapsid
surfac
spike
glycoprotein
nonstructur
protein
orf
kim
et
al
review
de
wit
et
al
particular
attent
understand
focus
spike
surfac
protein
confer
receptor
specif
qian
et
al
consid
major
determin
coronaviru
host
rang
graham
baric
hulswit
et
al
main
rout
entri
merscov
dipeptidyl
peptidas
also
known
host
cell
surfac
util
receptorbind
domain
merscov
spike
protein
chen
et
al
viru
readili
replic
human
lung
human
liver
wide
use
vero
african
green
monkey
kidney
cell
line
eckerl
et
al
among
other
cultur
vitro
ex
vivo
also
use
help
determin
cell
tropism
identifi
potenti
natur
host
viru
merscov
infect
varieti
human
cell
type
tissu
cultur
includ
macrophag
fibroblast
endotheli
cell
scobey
et
al
tao
et
al
hin
et
al
ex
vivo
studi
use
human
lung
explant
merscov
infect
alveolar
epitheli
cell
macrophag
type
ii
pneumocyt
result
alveolar
damag
hock
et
al
interestingli
although
kidney
failur
frequent
describ
fatal
case
viru
grow
well
number
kidney
liver
cell
line
one
autopsi
report
publish
viral
antigen
detect
immunohistochem
stain
pneumocyt
lung
interstiti
epitheli
cell
kidney
extrapulmonari
site
ng
et
al
replic
demonstr
goat
camel
eckerl
et
al
equid
origin
cell
line
detect
cattl
sheep
rodent
cell
line
test
eckerl
et
al
given
interest
bat
natur
host
mani
coronavirus
especi
sinc
sar
current
unknown
origin
merscov
sever
bat
cell
line
test
determin
could
support
merscov
replic
et
al
cai
et
al
eckerl
et
al
broad
gener
viru
report
replic
well
roughli
compar
growth
vero
cell
kidney
lung
cell
rousettu
aegyptiacu
old
world
pteropid
fruit
bat
et
al
cai
et
al
lesser
degre
cell
line
old
world
insectivor
bat
et
al
eckerl
et
al
littl
lung
cell
sever
new
world
bat
et
al
cai
et
al
howev
caveat
replic
found
rousettu
aegyptiacu
embryo
cell
line
test
cai
et
al
adapt
cell
bat
speci
normal
refractori
infect
somewhat
differ
protein
recent
demonstr
vitro
letko
et
al
result
select
spike
protein
mutat
permit
bind
new
similar
chang
bat
humantyp
receptor
observ
sar
letko
et
al
anim
model
merscov
includ
transgen
mice
express
human
cockrel
et
al
agraw
et
al
develop
respiratori
diseas
wide
use
model
marmoset
falzarano
et
al
rhesu
macaqu
yao
et
al
camel
barlan
et
al
hors
barlan
et
al
alpaca
adney
et
al
howev
anim
model
clearli
mimic
human
clinic
mer
review
basel
et
al
diagnost
assay
main
laboratori
assay
merscov
molecular
test
detect
viral
rna
serolog
prior
infect
cdc
world
health
organ
revers
transcript
pcr
either
real
time
convent
standard
diagnost
screen
pcr
primer
set
region
upstream
e
gene
upe
frequent
use
confirm
corman
et
al
corman
et
al
sensit
report
viral
gene
reaction
upe
copi
specif
approach
use
test
panel
known
coronavirus
clinic
respiratori
sampl
corman
et
al
pcr
report
compar
sensit
specif
upe
corman
et
al
commerci
kit
avail
compar
result
report
corman
et
al
seong
et
al
moham
et
al
sequenc
test
develop
may
better
suit
strain
differenti
target
region
rdrp
rna
polymeras
n
nucleocapsid
gene
corman
et
al
number
public
report
use
corman
et
al
cdc
anoth
pcr
test
target
spike
region
develop
monitor
circul
merscov
variant
abd
et
al
smit
et
al
type
nucleic
acid
test
also
use
shirato
et
al
immunohistochemistri
ng
et
al
serolog
sampl
usual
screen
use
enzymelink
immunosorb
assay
elisa
reusken
et
al
sampl
elisa
posit
cdc
agenc
formerli
recommend
confirmatori
test
first
immunofluoresc
assay
ifa
gold
standard
plaquereduct
neutral
test
microneutr
cdc
recommend
go
directli
microneutr
assay
cdc
revis
serolog
test
pseudoparticl
neutral
arraybas
serolog
reusken
et
al
also
develop
unfortun
pitfal
serolog
includ
crossreact
fals
neg
cdc
preliminarili
report
merscov
case
posit
elisa
ifa
later
retract
case
report
due
neg
microneutr
result
breakwel
et
al
consequ
cdc
longer
recommend
ifa
instead
recommend
use
two
differ
elisa
test
microneutr
confirm
cdc
revis
convers
low
wane
antibodi
respons
infect
would
yield
fals
neg
also
report
fals
neg
discuss
section
host
respons
clinic
find
describ
review
detail
assiri
et
al
rasmussen
et
al
world
health
organ
incub
period
day
case
day
assiri
et
al
assiri
et
al
fever
cough
short
breath
pneumonia
abnorm
chest
radiographi
frequent
note
sign
myalgia
diarrhea
vomit
abdomin
pain
chill
rigor
malais
also
seen
assiri
et
al
drosten
et
al
eckerl
et
al
gueri
et
al
ajlan
et
al
arabi
et
al
faur
et
al
scheuplein
et
al
hunter
et
al
renal
failur
pulmonari
failur
shock
commonli
describ
sever
fatal
case
overal
cfr
world
health
organ
viral
excret
respiratori
tract
document
first
month
ill
memish
et
al
spanaki
et
al
greater
viral
load
detect
lower
respiratori
tract
specimen
compar
upper
respiratori
tract
drosten
et
al
gueri
et
al
viral
excret
short
period
report
urin
stool
although
viral
load
low
drosten
et
al
least
one
report
merscov
secondari
case
individu
infect
primari
case
clear
infect
earlier
primari
case
memish
et
al
diseas
outcom
differ
age
comorbid
assiri
et
al
khalid
et
al
alsahafi
cheng
case
saudi
arabia
occur
among
men
age
older
live
area
lower
rel
humid
high
temperatur
alghamdi
et
al
review
case
saudi
arabia
found
cfr
increas
age
among
year
younger
among
year
older
alsahafi
cheng
mortal
frequent
rapid
individu
comorbid
diabet
chronic
renal
diseas
one
studi
higher
bodi
mass
index
assiri
et
al
khalid
et
al
alsahafi
cheng
sever
diseas
associ
higher
viral
load
feikin
et
al
hand
case
report
mer
outcom
vulner
popul
includ
three
case
pregnant
women
one
hivposit
individu
three
document
case
pregnant
women
merscov
infect
one
woman
second
trimest
pregnanc
month
experienc
stillbirth
mother
surviv
two
women
report
third
trimest
week
present
mer
healthi
infant
deliv
case
although
one
mother
die
despit
interferon
ifn
treatment
one
recov
despit
sever
symptom
alserehi
et
al
appar
healthi
infect
therefor
possibl
infect
third
trimest
may
associ
better
fetal
outcom
factor
may
critic
matern
outcom
number
small
gener
least
one
publish
case
individu
hivaid
acquir
merscov
shalhoub
et
al
patient
probabl
infect
merscov
hospit
stay
subsequ
shed
viru
day
patient
recov
treatment
shalhoub
et
al
number
studi
immun
function
corman
et
al
zhao
et
al
neutral
antibodi
detect
mani
patient
sever
studi
suggest
neutral
antibodi
induc
infect
appear
protect
corman
et
al
zhao
et
al
suggest
higher
antibodi
titer
may
close
correl
greater
viral
load
consequ
wors
prognosi
zhao
et
al
kinet
respons
may
also
import
antibodi
kinet
studi
patient
south
korea
research
group
later
report
wane
antibodi
titer
patient
followup
found
patient
produc
robust
neutral
igg
antibodi
respons
begin
week
peak
week
delay
respons
gener
correl
less
favor
prognosi
persist
antibodi
gener
seem
follow
similar
pattern
detect
neutral
antibodi
titer
report
patient
month
payn
et
al
howev
result
vari
consider
even
within
group
report
indic
durat
antibodi
respons
well
magnitud
seem
close
correl
diseas
sever
antibodi
could
low
even
absent
mild
asymptomat
infect
report
low
wane
antibodi
titer
especi
asymptomat
mildli
symptomat
individu
may
make
serolog
problemat
marker
popul
preval
evid
innat
immun
includ
ifn
cytokin
cellular
immun
presum
killer
cell
may
play
import
role
host
defens
recoveri
faur
et
al
zhao
et
al
zhao
et
al
compar
role
antibodi
cell
human
mer
case
found
survivor
mount
vigor
cell
respons
even
absenc
detect
antibodi
respons
macrophag
also
appear
play
import
role
limit
somewhat
ambigu
data
mous
model
human
cell
patient
faur
et
al
number
virus
unusu
rest
macrophag
permiss
replic
macrophag
show
antivir
activ
activ
ifnc
mors
morahan
dendrit
cell
report
produc
ifn
respons
infect
scheuplein
et
al
one
challeng
overcom
effect
viru
host
defens
caveat
much
research
although
done
vitro
may
necessarili
compar
immunolog
result
describ
patient
merscov
report
inhibit
host
innat
immun
impair
ifn
cytokin
respons
may
mediat
effect
base
assay
cell
mer
patient
faur
et
al
scheuplein
et
al
although
number
patient
small
vitro
studi
shown
merscov
could
downregul
express
ifnstimul
gene
subset
chemokin
mielech
et
al
ifnb
anoth
studi
found
merscov
may
caus
delay
induct
proinflammatori
cytokin
togeth
suppress
host
innat
antivir
respons
viru
replic
human
monocytederiv
macrophag
describ
increas
express
tumor
necrosi
factor
increas
normal
level
interleukin
almost
increas
interleukin
ifnc
chemokin
increas
even
promin
sarscov
report
current
main
treatment
strategi
symptomat
support
care
mechan
ventil
icu
admiss
usual
requir
sever
case
publish
data
appli
therapeut
regimen
merscov
patient
scarc
effort
develop
intervent
two
case
report
document
use
combin
ribavirin
ifn
therapi
merscov
patient
diverg
result
one
report
therapi
given
five
patient
five
die
howev
five
patient
comorbid
diagnos
late
cours
ill
suggest
therapi
may
deliv
late
prove
effect
anoth
report
therapi
given
one
patient
eventu
recov
khalid
et
al
retrospect
cohort
studi
patient
sever
mer
requir
ventilatori
support
treatment
ribavirin
pegyl
ifn
note
appear
increas
shortterm
surviv
day
although
day
patient
still
live
survivor
treat
group
compar
surviv
comparison
group
omrani
et
al
among
promis
studi
evalu
therapi
anim
model
one
vivo
studi
found
combin
ribavirin
ifn
therapi
significantli
improv
outcom
among
merscovinfect
rhesu
monkey
anoth
studi
use
common
marmoset
model
lopinavirritonavir
ifn
separ
combin
also
prove
promis
chan
et
al
although
neutral
antibodi
induc
infect
appear
protect
natur
infect
corman
et
al
zhao
et
al
human
convalesc
sera
contain
neutral
antibodi
confer
dosedepend
protect
mous
model
zhao
et
al
readili
avail
sera
mersimmun
camel
appar
also
effect
treatment
mersinfect
mice
reduc
sever
patholog
chang
murin
lung
tissu
sever
monoclon
antibodi
mab
ohnuma
et
al
jiang
et
al
tang
et
al
ying
et
al
houser
et
al
convent
antibodi
zhao
et
al
demonstr
effect
neutral
merscov
could
serv
potenti
therapeut
agent
least
interim
highthroughput
screen
method
identifi
addit
promis
compound
sever
class
de
wild
et
al
gao
et
al
shirato
et
al
adedeji
et
al
lundin
et
al
tao
et
al
wrensch
et
al
corti
et
al
liu
et
al
includ
inhibitor
viral
kilianski
et
al
lei
et
al
kumar
et
al
host
gierer
et
al
proteas
need
process
viru
howev
report
inhibit
proprotein
convertas
inhibit
host
cell
process
spike
protein
affect
viral
infect
celltocel
spread
gierer
et
al
target
studi
includ
viral
entri
inhibitor
zhao
et
al
du
et
al
protein
research
found
suppress
innat
antivir
respons
siu
et
al
vaccin
develop
develop
human
possibl
camel
vaccin
merscov
key
prioriti
given
concern
spread
pandem
potenti
vaccin
develop
long
process
often
driven
econom
modjarrad
much
focu
thu
far
center
identif
residu
within
receptorbind
domain
spike
protein
confer
best
chanc
protect
du
et
al
lan
et
al
et
al
number
antigen
viral
vector
test
laboratori
song
et
al
kim
et
al
replic
defect
fulllength
cdna
clone
merscov
genom
develop
identifi
futur
vaccin
candid
et
al
vaccin
candid
dromedari
camel
also
investig
report
elicit
protect
respons
use
merscov
spike
protein
poxviru
vector
haagman
et
al
special
challeng
develop
mer
vaccin
sporad
natur
human
merscov
infect
difficulti
identifi
suitabl
anim
model
challeng
studi
make
control
trial
difficult
diseas
camel
usual
appear
mild
adney
et
al
reduc
econom
incent
immun
camel
vaccin
could
also
given
combin
requir
vaccin
eg
rabi
suggest
wirblich
et
al
camelpox
suggest
haagman
et
al
correl
protect
durat
immun
also
uncertain
report
strong
antibodi
respons
haagman
et
al
suggest
presenc
neutral
antibodi
may
protect
camel
human
corman
et
al
zhao
et
al
wane
antibodi
titer
report
human
recov
merscov
infect
contrari
report
protect
mice
passiv
transfer
neutral
antibodi
suggest
might
overcom
optim
time
dose
zhao
et
al
research
merscov
vaccin
candid
ongo
least
one
candid
vaccin
progress
phase
human
clinic
trial
modjarrad
cepi
promis
develop
recent
launch
coalit
epidem
prepared
innov
cepi
list
mer
vaccin
one
initi
target
sourc
infect
primari
case
first
known
human
case
potenti
put
chain
transmiss
remain
unknown
baselin
incid
preval
unknown
clinic
case
found
contact
trace
gener
identifi
populationbas
studi
done
appear
show
low
preval
gener
popul
serolog
studi
individu
saudi
arabia
found
seroposit
merscov
occup
camelexpos
shepherd
slaughterhous
worker
although
occup
sampl
collect
separ
studi
therefor
may
repres
anoth
studi
person
suspect
merscov
infect
test
saudi
arabia
april
februari
test
posit
bin
saeed
et
al
work
done
symptomat
mer
patient
like
detect
identifi
even
one
analysi
suggest
least
even
symptomat
case
undetect
cauchemez
et
al
studi
use
data
travel
suggest
may
mani
sever
case
septemb
januari
time
number
case
confirm
determin
primari
versu
secondari
case
also
challeng
one
estim
merscov
primari
case
tend
mostli
middleag
male
compar
secondari
case
tend
younger
distribut
evenli
sex
gossner
et
al
offici
overal
cfr
stand
world
health
organ
howev
suggest
cfr
among
primari
case
estim
like
inflat
due
detect
bia
cfr
among
secondari
case
estim
cauchemez
et
al
main
known
exposur
health
careassoci
infect
contact
camel
asid
health
care
set
mechan
introduct
viru
human
popul
poorli
understood
occup
exposur
risk
also
poorli
character
health
care
work
camel
sar
mani
case
health
care
facilityassoci
drosten
et
al
mechan
infect
unclear
mani
individu
fanoy
et
al
activ
case
find
typic
among
perceiv
risk
group
hospit
pneumonia
use
vari
success
identifi
case
gierer
et
al
aburizaiza
et
al
memish
et
al
nosocomi
transmiss
due
inadequ
infect
control
well
establish
signific
driver
merscov
infect
human
alabdallat
et
al
oboho
et
al
assiri
et
al
hast
et
al
notabl
spring
outbreak
saudi
arabia
late
spring
outbreak
south
korea
review
known
merscov
case
time
review
use
publicli
avail
data
found
possibl
confirm
health
careassoci
transmiss
event
lead
substanti
morbid
mortal
often
involv
patient
comorbid
infect
control
laps
appar
respons
virtual
report
health
care
transmiss
event
highlight
need
strengthen
infect
control
capac
worldwid
howev
specif
breach
infect
control
usual
identifi
probabl
vari
highrisk
procedur
identifi
usual
aerosol
gener
procedur
includ
hemodialysi
respiratori
intens
care
assiri
et
al
secondarili
infect
health
care
worker
tend
milder
symptom
better
prognos
outbreak
saudi
arabia
one
studi
analyz
symptomat
case
merscov
found
health
care
worker
addit
infect
health
care
worker
asymptomat
total
case
analyz
health
care
worker
patient
contact
health
care
facil
oboho
et
al
cluster
merscov
case
jordan
health
care
worker
outbreak
hospit
merscov
transmiss
detect
transfer
hospit
adequ
infect
control
alabdallat
et
al
health
careassoci
outbreak
occur
south
korea
late
spring
juli
aris
one
infect
individu
return
gulf
state
cowl
et
al
hui
et
al
analysi
south
korean
merscov
case
use
publicli
avail
data
delin
three
gener
secondari
infect
half
case
second
gener
lee
wong
overal
case
hospitalassoci
lee
wong
primarili
affect
nonhealth
care
worker
spread
condit
close
contact
patient
crowd
hospit
emerg
room
lee
patient
switch
facil
lee
lee
direct
contact
could
infer
case
author
suggest
fomit
transmiss
could
import
wong
seo
et
al
also
review
otter
et
al
earlier
report
demonstr
merscov
rel
stabl
environ
report
recover
surfac
h
rel
humid
least
h
humid
van
doremalen
et
al
liquid
h
leclercq
et
al
studi
four
laboratoryconfirm
merscov
patient
room
two
south
korean
hospit
merscov
viral
rna
found
environment
surfac
includ
bedsheet
medic
equip
day
patient
last
pcrposit
respiratori
specimen
viabl
viru
also
detect
seo
et
al
howev
appar
report
infect
hospit
laundri
mainten
worker
contrari
would
expect
environment
transmiss
possibl
identifi
report
could
find
two
public
specif
mention
infect
hospit
cleaner
hast
et
al
liu
et
al
hast
et
al
investig
outbreak
king
fahd
gener
hospit
report
merscov
case
among
mainten
housekeep
personnel
howev
appear
symptomat
case
test
specif
detail
case
provid
mani
report
contact
trace
identifi
famili
member
friend
cowork
person
close
contact
patient
includ
report
saudi
arabia
memish
et
al
omrani
et
al
well
unit
kingdom
pebodi
et
al
health
protect
agenc
hpa
uk
novel
coronaviru
investig
team
thoma
et
al
iran
yavarian
et
al
tunisia
abroug
et
al
china
wu
et
al
greec
germani
buchholz
et
al
reuss
et
al
malaysia
premila
devi
et
al
franc
maill
et
al
itali
puzelli
et
al
famili
cluster
identifi
number
report
small
percentag
contact
becam
case
suggest
close
contact
import
risk
factor
health
careassoci
transmiss
direct
humantohuman
transmiss
appear
limit
although
outbreak
south
korea
also
involv
close
contact
among
famili
member
patient
hospit
room
may
appropri
categor
health
careassoci
transmiss
kang
et
al
howev
rel
littl
inform
asymptomat
individu
detect
contact
trace
one
studi
asymptomat
health
care
worker
excret
merscov
week
algethami
et
al
spring
outbreak
saudi
arabia
estim
laboratoryconfirm
merscov
asymptomat
oboho
et
al
analysi
merscov
patient
unit
arab
emir
found
asymptomat
individu
yield
posit
lower
respiratori
tract
specimen
week
al
hammadi
et
al
report
two
asymptomat
men
contact
infect
camel
infect
confirm
pcr
men
eight
camel
group
al
hammadi
et
al
howev
actual
frequenc
asymptomat
individu
compar
symptomat
individu
larg
unknown
paramet
transmiss
dynam
import
mathemat
model
spread
due
heterogen
transmiss
import
characterist
infect
dynam
r
basic
reproduct
rate
suscept
popul
difficult
pinpoint
estim
rang
breban
et
al
poletto
et
al
cauchemez
et
al
r
requir
outbreak
selfsustain
anderson
may
specif
locat
one
model
suggest
r
jeddah
riyadh
majumd
et
al
like
correct
effect
superspread
health
care
set
kucharski
althau
one
mathemat
model
suggest
risk
secondari
transmiss
follow
import
merscov
case
ci
risk
gener
estim
respect
nishiura
et
al
travelrel
case
despit
mass
gather
individu
annual
hajj
pilgrimag
khan
et
al
date
result
known
merscov
transmiss
event
barashe
et
al
benkouiten
et
al
gautret
et
al
memish
et
al
aberl
et
al
annan
et
al
confirm
model
estim
hajj
lessler
et
al
two
travel
return
netherland
separ
pilgrimag
umrah
may
found
merscov
mani
travelrel
case
tabul
pavli
et
al
sridhar
et
al
case
casual
transmiss
outsid
famili
health
care
set
observ
dromedari
camel
document
zoonot
sourc
human
infect
consider
circumstanti
evid
support
cameltohuman
transmiss
includ
evid
camel
human
becom
infect
ident
merscov
ferguson
kerkhov
ident
genom
sequenc
merscov
isol
camel
owner
die
merscov
camel
rhinorrhea
time
ident
merscov
rna
fragment
later
detect
air
camel
barn
serolog
suggest
camel
infect
owner
critic
suggest
ident
sequenc
may
due
crosscontamin
author
maintain
isol
collect
differ
day
process
differ
facil
epidemiolog
investig
found
similar
evid
direction
impli
ferguson
kerkhov
memish
et
al
outbreak
site
viral
genom
sequenc
camel
match
publish
human
one
analysi
merscov
among
camel
show
mani
camel
virus
classifi
clade
correl
human
outbreak
alagaili
et
al
interestingli
three
dromedari
camel
strain
merscov
similar
viral
replic
compet
human
strain
cell
human
respiratori
tract
explant
evid
suggest
camel
would
appear
involv
crossspeci
transmiss
merscov
although
precis
mechan
frequenc
remain
uncertain
occup
exposur
camel
would
seem
particularli
strong
risk
factor
infect
rel
import
rel
risk
differ
exposur
well
document
hemida
et
al
camel
wide
use
region
varieti
purpos
mani
peopl
contact
camel
exposur
often
invok
nonoccup
primari
case
assess
camel
exposur
complic
vari
sometim
vagu
definit
use
classifi
camel
exposur
multipl
type
possibl
exposur
even
hypothes
camel
exposur
commonli
underreport
gossner
et
al
critic
need
clearer
definit
measur
camel
exposur
standard
methodolog
evid
date
indic
merslik
coronavirus
circul
camel
sinc
least
first
detect
merscov
human
seroposit
found
consist
african
middl
eastern
camel
sinc
tabl
virolog
evid
merscov
infect
camel
qatar
ferguson
kerkhov
egypt
ali
et
al
oman
nowotni
kolodziejek
saudi
arabia
sudan
elsewher
ali
et
al
increas
genom
evid
suggest
divers
coronavirus
camel
throughout
middl
east
africa
includ
major
sourc
countri
camel
import
middl
east
crossneutr
merscov
diverg
sequenc
probabl
human
pathogen
chu
et
al
may
explain
high
appar
seroposit
camel
africa
absenc
known
human
case
mer
mainten
viru
camel
popul
remain
open
question
symptomat
merscov
infect
document
calv
adult
camel
adney
et
al
viral
shed
detect
nasal
secret
day
postinocul
merscov
adney
et
al
well
milk
possibl
fece
reusken
et
al
camel
milk
suggest
possibl
sourc
infect
human
camel
foal
reusken
et
al
one
studi
demonstr
ad
merscov
surviv
milk
least
h
although
detect
pasteur
possibl
livestock
host
merscov
investig
gener
neg
hemida
et
al
reusken
et
al
alagaili
et
al
alexandersen
et
al
one
studi
found
seroposit
alpaca
member
camelid
famili
qatar
reusken
et
al
experiment
infect
alpaca
one
studi
demonstr
upper
respiratori
tract
infect
viral
shed
transmiss
alpaca
adney
et
al
search
origin
natur
host
merscov
continu
bat
speci
across
world
known
host
wide
varieti
coronavirus
includ
betacoronavirus
genu
merscov
belong
anthoni
et
al
lelli
et
al
memish
et
al
bat
tend
show
greater
coronaviru
divers
mammal
drexler
et
al
consequ
much
research
focus
possibl
origin
merscov
bat
possibl
support
hypothesi
bat
cell
line
merscov
report
replic
cell
line
express
function
human
receptor
viru
bat
cell
line
lack
express
cai
et
al
possibl
merscov
may
rel
new
introduct
human
phylogenet
analysi
util
complet
partial
complet
merscov
genom
sequenc
saudi
arabian
case
estim
recent
common
ancestor
march
ci
decemb
cotten
et
al
one
studi
analysi
subunit
spike
gene
suggest
merscov
may
arisen
intraspik
recombin
two
ancestr
coronavirus
viru
isol
bat
although
portion
merscov
rna
sequenc
appar
identifi
bat
insectivor
bat
taphoz
perforatu
egyptian
tomb
bat
saudi
arabia
site
earli
human
case
nucleotid
match
although
nucleotid
rel
wellconserv
rdrp
region
memish
et
al
merslik
coronavirus
includ
close
relat
also
use
receptor
first
identifi
woo
et
al
woo
et
al
matthew
et
al
other
identifi
bat
speci
china
matthew
et
al
mexico
anthoni
et
al
south
africa
ithet
et
al
corman
et
al
uganda
sinc
detect
merscov
larg
bodi
research
amass
evidenc
hundr
uniqu
result
databas
search
viru
rapidli
character
function
human
receptor
swiftli
identifi
speci
cellular
tropism
studi
complement
clinic
investig
laboratori
work
provid
insight
merscov
pathogenesi
observ
research
outbreak
middl
east
south
korea
gener
grow
repositori
clinic
data
basic
epidemiolog
genom
sequenc
studi
evalu
role
humananim
interfac
health
care
set
famili
cluster
travel
merscov
transmiss
furthermor
bat
implic
possibl
origin
merscov
dromedari
camel
shown
like
sourc
mani
human
infect
progress
develop
therapeut
vaccin
although
yet
progress
full
clinic
trial
could
forese
futur
major
reason
undertook
review
determin
gap
still
exist
public
origin
identifi
largest
categori
public
laboratori
basic
scienc
studi
follow
surveil
anim
interfac
clinic
aspect
health
care
therapeut
vaccin
human
transmiss
epidemiolog
one
sparsest
includ
investig
hospit
outbreak
travelrel
case
note
categori
necessarili
exclus
overlap
gener
continu
surveil
merscov
affect
countri
continu
priorit
surveil
human
camel
bat
given
appar
import
serolog
may
reliabl
due
crossreact
possibl
wane
antibodi
virolog
surveil
sequenc
also
attempt
select
specimen
whenev
feasibl
although
role
bat
yet
fulli
elucid
evid
lack
bat
sourc
human
infect
divers
coronavirus
includ
merslik
coronavirus
bat
speci
across
globe
indic
continu
research
ongo
surveil
coronavirus
bat
justifi
lelli
et
al
number
key
gap
remain
epidemiolog
includ
transmiss
populationbas
incid
preval
rate
geograph
demograph
distribut
infect
base
limit
human
seropreval
data
far
seem
like
popul
preval
low
baselin
establish
also
clear
whether
seroposit
reliabl
indic
prior
infect
find
variabl
low
antibodi
titer
year
postinfect
indic
method
tradit
serosurvey
may
requir
reusken
et
al
serolog
reliabl
rais
question
screen
popul
method
sensit
specif
antibodi
detect
mishra
et
al
well
assay
cellular
immun
zhao
et
al
costlier
difficult
popul
screen
contact
trace
identifi
asymptomat
infect
studi
frequenc
transmiss
limit
mani
infect
health
care
worker
question
could
systemat
studi
rel
littl
known
natur
histori
human
asymptomat
infect
studi
viru
shed
seroconvers
transmiss
asymptomat
infect
need
evid
suggest
secondari
case
lower
averag
cfr
subsequ
link
chain
merscov
infect
may
decreas
sever
exposur
primari
case
still
larg
inferenti
best
camel
appar
often
like
sourc
definit
camel
exposur
vari
prevent
clear
epidemiolog
infer
definit
exposur
methodolog
metric
determin
exposur
clarifi
standard
even
camel
princip
sourc
human
infect
would
still
explain
substanti
portion
primari
human
case
appar
camel
exposur
infect
rais
question
primari
case
acquir
merscov
infect
whether
anim
speci
unidentifi
zoonot
exposur
unrecogn
infecti
person
asymptomat
infecti
individu
environment
contamin
consequ
clarifi
rout
transmiss
remain
crucial
receiv
emphasi
date
compel
evid
direct
humantohuman
transmiss
droplet
secondari
infect
report
often
unclear
health
care
worker
becom
infect
possibl
evid
environment
contamin
fomit
health
care
set
nosocomi
transmiss
close
contact
activ
merscov
case
variou
infect
control
laps
document
rare
specif
event
rout
ben
embarek
van
kerkhov
alraddadi
et
al
van
kerkhov
et
al
rigor
infect
control
therefor
remain
essenti
could
prevent
mani
secondari
case
interim
better
document
identif
specif
laps
led
infect
would
great
valu
understand
mechan
transmiss
one
greatest
knowledg
gap
much
evid
fomit
transmiss
exampl
remain
anecdot
van
kerkhov
et
al
mechan
support
chain
human
merscov
transmiss
need
fulli
evalu
gap
indic
need
addit
research
also
consist
terminolog
clear
definit
although
epidemiolog
literatur
merscov
larg
much
fragment
inconsist
report
often
difficult
deduc
sequenc
infect
relationship
case
specif
exposur
comprehens
consist
databas
registri
prioriti
genom
sequenc
prove
use
sever
respect
genom
sequenc
use
help
determin
viral
circul
ancestri
cotten
et
al
differenti
appar
similar
serolog
crossreact
coronavirus
camel
address
still
unresolv
question
mer
seem
region
limit
mani
camel
import
place
chu
et
al
also
use
reconstruct
transmiss
event
help
establish
chain
infect
assiri
et
al
must
note
press
need
rigor
convent
epidemiolog
well
valid
methodolog
approach
might
well
serv
complementari
function
advanc
understand
remain
need
effect
therapeut
vaccin
treatment
remain
symptomat
insuffici
clinic
data
therapeut
option
option
alway
limit
number
develop
approach
systemat
share
protocol
critic
comparison
result
number
drug
vaccin
candid
identifi
may
option
avail
futur
clinic
trial
appear
effort
underway
develop
clinic
trial
base
standard
protocol
need
despit
challeng
present
sporad
natur
case
rel
rariti
clinic
mer
sever
limit
systemat
review
merscov
public
english
english
languag
abstract
elig
inclus
although
case
arabicspeak
area
korea
howev
hundr
english
languag
report
avail
countri
around
world
includ
middl
east
south
korea
minim
concern
second
review
contain
public
index
databas
juli
possibl
public
especi
recent
publish
articl
manuscript
still
product
unintent
exclud
review
updat
literatur
review
period
prepar
articl
minim
number
miss
public
third
gray
literatur
includ
govern
report
technic
document
meet
abstract
although
like
import
find
would
submit
journal
public
emerg
infect
zoonot
origin
mors
unifi
one
health
approach
engag
human
health
livestock
companion
anim
wildlif
environ
sector
crucial
deal
mer
mors
mors
et
al
could
serv
excel
case
studi
epidemiolog
respons
new
zoonot
emerg
infect
